Showing results (51-60 of 125) with videos related to
Sort By:
Pageof 13
Oncology|September 23, 2020
Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNASaranya Akumalla, Russell Madison, Douglas I Lin, et al.European Urology|September 18, 2012
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneityHimisha Beltran, Roman Yelensky, Garrett M Frampton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancerStéphane Vignot, Garrett M Frampton, Jean-Charles Soria, et al.Cancer Research|February 26, 2017
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer PathogenesisRyan J Hartmaier, Lee A Albacker, Juliann Chmielecki, et al.Pigment Cell & Melanoma Research|November 25, 2017
BRAF internal deletions and resistance to BRAF/MEK inhibitor therapyDouglas B Johnson, Merrida A Childress, Zachary R Chalmers, et al.JCO Precision Oncology|October 20, 2022
Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA SamplesHatim Husain, Dean C Pavlick, Bernard J Fendler, et al.The Lancet. Digital Health|May 26, 2023
Comprehensive genomic profiling and treatment patterns across ancestries in advanced prostate cancer: a large-scale retrospective analysisSmruthy Sivakumar, Jessica K Lee, Jay A Moore, et al.JCO Precision Oncology|September 9, 2020
Pan-Cancer Analysis of <i>BRCA1</i> and <i>BRCA2</i> Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of HeterozygosityEthan S Sokol, Dean Pavlick, Hossein Khiabanian, et al.Proceedings of the National Academy of Sciences of the United States of America|July 31, 2020
An ErbB2 splice variant lacking exon 16 drives lung carcinomaHarvey W Smith, Lei Yang, Chen Ling, et al.The Oncologist|March 12, 2017
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common <i>CDKN2A</i> AlterationJulia A Elvin, Laurie M Gay, Rita Ort, et al.Pageof 13